Catalyst Wire Dossier Catalyst Wire Dossier

Enobosarm

enobosarm · Veru Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Enobosarm, covering 2020-11-12 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss [Phase 2]

See pricing